Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, July 20, 2023. Fast Five by MassDevice · Masimo aims to reduce costs, Ascensia Diabetes Care inks new deal in Canada Aetna’s policy update expanding […]
Featured
Aetna policy update expands access to Neuronetics NeuroStar
Neuronetics (Nasdaq:STIM) announced today that a healthcare policy update from Aetna increases access to its NeuroStar therapy. Malvern, Pennsylvania-based Neuronetics develops products aimed at improving the life of patients with neuro health disorders. NeuroStar, a non-drug, non-invasive treatment can improve the quality of life for neuro health patients when traditional medication fails. The transcranial magnetic […]
Ascensia Diabetes Care inks deal to integrate blood glucose monitors in point-of-care testing
Avricore Health and Ascensia Diabetes Care announced a partnership to integrate blood glucose monitoring into point-of-care testing. The deal aims to integrate the Contour Next-Gen and Contour Next One BGM systems into Avricore’s HealthTab PCOT platform. Both companies have the objective of supporting patients and pharmacists in Canada to better manage diabetes. The companies believe […]
Masimo expects to cut 2023 healthcare sales guidance by $150M, aims to reduce costs
Masimo announced preliminary second-quarter results that include a potentially significant reduction in sales guidance. Full-year guidance for Masimo’s healthcare business, previously set at $1.45 billion at the low end, is expected to be slashed to $1.3 billion. The company also said yesterday that it is still evaluating the upper end of its guidance, which could […]
Fast Five: Medtronic has a Class I recall of some ICDs, Endologix completes first procedures using Detour system
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, July 19, 2023. Fast Five by MassDevice · Medtronic has a Class I recall, Endologix completes first procedures using Detour system The appointment of a […]
Philips enrolls first patients in stroke diagnosis, treatment trial in France, U.S.
Philips announced today that its WE-TRUST clinical trial enrolled its first patients in France and the U.S. The trial aims to evaluate whether a direct-to-angio suite (DTAS) workflow can improve outcomes for early time-window stroke patients. It compares this method to the conventional approach that uses a diagnostic MR/CT scan before transfer to the angio […]
Medtronic recalls certain implantable cardiac defibrillators due to potential low energy output
The FDA designated a recall of some Medtronic defibrillators as Class I, the most serious kind. Medtronic’s recall affects implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). Affected products include the Cobalt XT, Cobalt and Crome ICDs and CRT-Ds, plus the Claria MRI, Amplia MRI, Compia MRI, Viva and Brava CRT-Ds. The recall […]
Endologix completes first procedures using Detour system to kick off U.S. launch
Endologix announced today that the first patients underwent a procedure using its Detour system since it received FDA approval. The FDA approved Detour for use in percutaneous transmural arterial bypass (PTAB) to treat peripheral arterial disease (PAD) last month. This initial procedure marks the official start of the company’s targeted market release of Detour in […]
Fast Five: Leading U.S. hospital begins pediatric program with Asensus surgical robot platform, Philips to repurchase up to 7.1M shares
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, July 18, 2023. Fast Five by MassDevice · U.S. hospital begins pediatric program with Asensus surgical robot, Philips to repurchase shares Tivic Health’s successful pricing […]
CurvaFix raises $39M, announces new CEO
CurvaFix announced today that it closed a $39 million equity financing and named Mark Foster as its new CEO. Foster succeeds founder and current CEO Steve Dimmer to take over the corner office. The Bellevue, Washington-based company develops medical devices for repairing fractures in curved bones. Dimmer intends to transition into a strategic advisory role […]
Relievant Medsystems unveils new tools for its ablation system
Relievant Medsystems announced today that it launched its next-generation access instruments for the Intracept procedure. Intracept — a minimally invasive, FDA-cleared, same-day, outpatient procedure — treats chronic vertebrogenic low back pain. It uses targeted radiofrequency energy to ablate the basivertebral nerve (BVN). This stops the nerve it from transmitting pain signals to the brain. The […]